Breaking News, Collaborations & Alliances, Promotions & Moves

Alkermes Announces Grant Recipients

The 1st Annual Alkermes Pathways Research Awards (SM) Program granted approximately $400,000 for research projects focused on substance use disorders

Alkermes plc has announced the recipients of the ALKERMES PATHWAYS RESEARCH AWARDS program, designed to support the next generation of researchers working on the front lines to advance understanding and awareness of central nervous system (CNS) disorders.  In its inaugural year, the Pathways program will provide an aggregate of $400,000 in grants to junior investigators who have demonstrated their commitment to helping those living with substance use disorders (SUD), including those associ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters